Teiji Tominaga

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Tohoku University, Biogen Ma Inc., Corxel Pharmaceuticals Hong Kong Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teiji Tominaga. Retrieved from https://idiyas.com/inventor/teiji-tominaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 88.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Miyagi, JP (2018 - 2019)
Sendai, JP (2020 - 2023)

Company Filing History:

Corxel Pharmaceuticals Hong Kong Limited

patents

4. 1 out of 1

Kake Education Institution

patent

5. 1 out of 1

Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center

patent

6. 1 out of 3

Life Science Institute, Inc.

patents

7. 1 out of 27

Nippon Kayaku Co., Ltd

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599631 - Agent for treating or preventing vascular dementia (2026-04-14),

2. 12453718 - Drug for treating or preventing cerebral hemorrhage, and method for treating or preventing cerebral hemorrhage using the drug (2025-10-28),

3. 12288328 - Blood flow field estimation apparatus, learning apparatus, blood flow field estimation method, and program (2025-04-29),

4. 11850232 - Drug for treating or preventing cerebral hemorrhage, and method for treating or preventing cerebral hemorrhage using the drug (2023-12-26),

5. 10993966 - Pluripotent stem cell for treatment of cerebral infarction (2021-05-04),

6. 10758484 - CED of SN-38-loaded micelles against brain tumor (2020-09-01),

7. 10463647 - Erythropoietin expression promoter (2019-11-05),

8. 10028766 - Jet stream generating device and jet stream generating method (2018-07-24),

9. 10004718 - Erythropoietin expression promoter (2018-06-26),

Title: Teiji Tominaga: Innovator in Medical Technology

Introduction

Teiji Tominaga is a prominent inventor based in Miyagi, Japan, known for his significant contributions to medical technology. With a total of seven patents to his name, Tominaga has focused on developing innovative solutions that address critical health issues.

Latest Patents

Among his latest patents is a blood flow field estimation apparatus. This apparatus includes an estimation unit that utilizes a learned model obtained through machine learning. It learns the relationship between organ tissue three-dimensional structure data and the blood flow field in the organ. The output unit of the apparatus provides an estimation result based on the organ tissue data. Another notable patent is a drug for treating or preventing cerebral hemorrhage. This drug contains a compound represented by a specific formula, aimed at providing effective treatment options for this serious condition.

Career Highlights

Teiji Tominaga has worked with esteemed institutions such as Tohoku University and Kake Education Institution. His work in these organizations has allowed him to collaborate on various research projects that have advanced the field of medical technology.

Collaborations

Tominaga has collaborated with notable colleagues, including Takaaki Abe and Kenichiro Hayashi. Their combined expertise has contributed to the successful development of innovative medical solutions.

Conclusion

Teiji Tominaga's work exemplifies the impact of innovation in the medical field. His patents reflect a commitment to improving healthcare through technology. His contributions continue to pave the way for advancements in medical treatments and diagnostics.

Profile summary based on public USPTO records.